Green Cross TD Vaccine (GC1107)
/ GC Biopharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
January 29, 2019
A Phase III Study to Evaluate the Immunogenicity and Safety of GC1107 (Adult Tetanus Diphtheria Vaccine) in Healthy Adults.
(PubMed, J Korean Med Sci)
- P3; "This phase III study demonstrated non-inferiority in immunogenicity and comparable safety of GC1107 compared with the control Td vaccine. ClinicalTrials.gov Identifier: NCT02361866."
Clinical • Journal • P3 data
1 to 1
Of
1
Go to page
1